Industry reports
Editor highlights

Herbal traditional Products in Brazil Feb Edition

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 166 pages

Includes 3 FREE quarterly updates BMI View: Brazil remains the most attractive emerging pharmaceutical industry in the Americas due to its large population, strong consumer demand, increasing urbanisation and comparatively good drug regulatory environment. Many multinational pharmaceutical industry players ...

Industries: Drug and Medication | Countries: Brazil

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • January 2014
  • 38 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Aspen Pharmacare Holdings Ltd SWOT Analysis report provides you a ...

Industries: Drug and Medication | Countries: Australia, South Africa, World, Brazil, Mexico, Germany, Tanzania, Kenya, Africa, Venezuela, Mauritius

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2013
  • 163 pages

BMI View: Brazil’s large population, combined with strong private consumption, bodes well for foreign drugmakers looking to capitalise on the growth trajectory of Latin America’s largest healthcare industry . Ranked as the world’s eighth largest pharmaceutical industry by size, we anticipate patented ...

Industries: Drug and Medication | Countries: Brazil

Brazilian Pharmaceutical Market 2014-2024

Brazilian Pharmaceutical Market 2014-2024

  • $ 2 776
  • Industry report
  • by Visiongain
  • November 2013
  • 150 pages

Report Details Drug selling in Brazil - this new analysis shows you trends, opportunities, and revenues Do you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's new report gives you revenue predictions, helping your work. There you discover financial results, ...

Industries: Drug and Medication | Countries: Brazil

Global Intravenous (IV) Iron Drugs Industry

Global Intravenous (IV) Iron Drugs Industry

  • $ 4 500
  • Industry report
  • by Global Industry Analysts
  • October 2013
  • 120 pages

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. ...

Industries: Drug and Medication | Countries: World, United States, Europe, Japan, Germany, Canada, France, China, Spain, Russian Federation, Italy, India, Switzerland, North America, United Kingdom, South America, Brazil

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • by Global Data
  • September 2013
  • 80 pages

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022”. Meningococcal disease is an acute infection caused by the gram-negative ...

Industries: Drug and Medication | Countries: Brazil

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • September 2013
  • 44 pages

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these ...

Industries: Drug and Medication | Countries: Australia, World, Brazil, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, China, Oceania, South America

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • September 2013
  • 44 pages

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. Fo ...

Industries: Drug and Medication | Countries: World, Brazil, Spain, Italy, France, Germany, Japan, Europe, Australia, United States, United Kingdom, China

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • September 2013
  • 43 pages

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. Fo ...

Industries: Drug and Medication | Countries: Spain, World, Brazil, Italy, France, Germany, Japan, United Kingdom, Australia, Europe, United States, China

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • September 2013
  • 41 pages

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. Fo ...

Industries: Drug and Medication | Countries: World, Australia, Brazil, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, Oceania

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.